DE69832066D1 - Verwendung eines oligosaccharids zur vorbeugung von blutgerinnung in extrakorporale kreisläufe - Google Patents

Verwendung eines oligosaccharids zur vorbeugung von blutgerinnung in extrakorporale kreisläufe

Info

Publication number
DE69832066D1
DE69832066D1 DE69832066T DE69832066T DE69832066D1 DE 69832066 D1 DE69832066 D1 DE 69832066D1 DE 69832066 T DE69832066 T DE 69832066T DE 69832066 T DE69832066 T DE 69832066T DE 69832066 D1 DE69832066 D1 DE 69832066D1
Authority
DE
Germany
Prior art keywords
oligosaccharide
climbing
preventing blood
extracorporeal circuits
extracorporeal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69832066T
Other languages
English (en)
Other versions
DE69832066T2 (de
Inventor
Marc Herbert
Christianus Stiekema
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Aventis France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France
Application granted granted Critical
Publication of DE69832066D1 publication Critical patent/DE69832066D1/de
Publication of DE69832066T2 publication Critical patent/DE69832066T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
DE69832066T 1997-05-27 1998-05-22 Verwendung eines oligosaccharids zur vorbeugung von blutgerinnung in extrakorporalen kreisläufen Expired - Lifetime DE69832066T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97201586 1997-05-27
EP97201586 1997-05-27
PCT/EP1998/003174 WO1998053829A1 (en) 1997-05-27 1998-05-22 Use of oligosaccharide for preventing blood clotting in extracorporeal blood circuits

Publications (2)

Publication Number Publication Date
DE69832066D1 true DE69832066D1 (de) 2005-12-01
DE69832066T2 DE69832066T2 (de) 2006-07-13

Family

ID=8228366

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69832066T Expired - Lifetime DE69832066T2 (de) 1997-05-27 1998-05-22 Verwendung eines oligosaccharids zur vorbeugung von blutgerinnung in extrakorporalen kreisläufen

Country Status (12)

Country Link
US (3) US6391339B1 (de)
EP (2) EP1593380A3 (de)
JP (2) JP2002503270A (de)
AT (1) ATE307596T1 (de)
AU (1) AU8211398A (de)
BR (1) BR9809478A (de)
CA (1) CA2289522A1 (de)
DE (1) DE69832066T2 (de)
DK (1) DK0984785T3 (de)
ES (1) ES2251090T3 (de)
NO (1) NO325142B1 (de)
WO (1) WO1998053829A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1593380A3 (de) * 1997-05-27 2008-06-11 Sanofi-Aventis Verwendung eines Oligosaccharids zur Vorbeugung von Blutgerinnung in extrakorporale Kreisläufe
FR2804328B1 (fr) 2000-01-27 2002-03-15 Hospal Ind Membrane semi-permeable non thrombogene et procede de fabrication
JP2006096668A (ja) * 2002-11-08 2006-04-13 Ono Pharmaceut Co Ltd エラスターゼ阻害剤と血液凝固系および／または線溶系酵素阻害剤との組み合わせからなる医薬
KR101716241B1 (ko) * 2009-12-01 2017-03-14 엑스테라 메디컬 코퍼레이션 표면 고정화된 다당류를 이용하여 혈액으로부터 사이토카인을 제거하는 방법
EP2861273B1 (de) 2012-06-13 2017-08-23 ExThera Medical Corporation Verwendung von heparin und kohlenhydraten zur behandlung von krebs
CN105705177B (zh) 2013-11-08 2019-10-22 艾克塞拉医疗公司 使用吸附介质诊断感染性疾病的方法
WO2015164198A1 (en) 2014-04-24 2015-10-29 Exthera Medical Corporation Method for removing bacteria from blood using high flow rate
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2002A (en) * 1841-03-12 Tor and planter for plowing
DE3008993A1 (de) * 1980-03-08 1981-10-01 Röhm Pharma GmbH, 6100 Darmstadt Pharmazeutische zubereitungen
US4331697A (en) * 1980-09-02 1982-05-25 Teijin Limited Novel heparin derivative, method for production thereof, and method for rendering biomedical materials antithrombotic by use of the novel heparin derivative
US4818816A (en) * 1981-04-28 1989-04-04 Choay, S.A. Process for the organic synthesis of oligosaccharides and derivatives thereof
US4987223A (en) * 1981-12-23 1991-01-22 Choay S.A. Derivatives of the uronic acid
US4801583A (en) * 1982-01-15 1989-01-31 Choay S.A. Oligosaccharides and their biological applications
AU563351C (en) * 1982-01-15 2003-06-19 Glaxo Group Limited Synthesis of oligosaccharides
JPS63218691A (ja) * 1987-03-09 1988-09-12 Rikagaku Kenkyusho 新規な５糖類化合物及びその製造法並びに抗凝血及び抗血栓剤
EP0300099A1 (de) * 1987-07-20 1989-01-25 Akzo N.V. Pentasaccharide
US5256559A (en) * 1988-03-04 1993-10-26 Biogen, Inc. Methods and compositions for inhibiting platelet aggregation
US5252213A (en) * 1989-06-20 1993-10-12 University Of Washington Dry dialysate composition
US5378829A (en) * 1990-04-23 1995-01-03 Akzo N.V. Sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type
WO1993005825A1 (en) * 1991-09-20 1993-04-01 Baxter International Inc. Processes for reducing the thrombogenicity of biomaterials
ITPD940054A1 (it) * 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
US6391369B1 (en) * 1996-03-27 2002-05-21 Bunge Foods Corporation Selectively hydrogenated high oleic oil compositions and process
IL120722A (en) * 1996-05-08 1999-07-14 Akzo Nobel Nv Polysulfated tetrasaccharide derivatives and pharmaceutical compositions containing them
EP1593380A3 (de) * 1997-05-27 2008-06-11 Sanofi-Aventis Verwendung eines Oligosaccharids zur Vorbeugung von Blutgerinnung in extrakorporale Kreisläufe

Also Published As

Publication number Publication date
JP2002503270A (ja) 2002-01-29
AU8211398A (en) 1998-12-30
NO995800D0 (no) 1999-11-26
US6391339B1 (en) 2002-05-21
CA2289522A1 (en) 1998-12-03
DE69832066T2 (de) 2006-07-13
DK0984785T3 (da) 2006-01-30
EP1593380A3 (de) 2008-06-11
EP1593380A2 (de) 2005-11-09
EP0984785A1 (de) 2000-03-15
BR9809478A (pt) 2000-06-20
US20020040012A1 (en) 2002-04-04
ES2251090T3 (es) 2006-04-16
NO325142B1 (no) 2008-02-11
ATE307596T1 (de) 2005-11-15
WO1998053829A1 (en) 1998-12-03
US20070197637A1 (en) 2007-08-23
JP2010013455A (ja) 2010-01-21
NO995800L (no) 1999-11-26
EP0984785B1 (de) 2005-10-26

Similar Documents

Publication Publication Date Title
ATE425139T1 (de) Benzamidinderivate
BR0116519B1 (pt) cartucho de hemodiafiltraÇço/hemofiltraÇço de diluiÇço intermediÁria.
ES2120132T3 (es) Aductos de bisulfito de argininaldehidos utiles como inhibidores de la trombina y anticoagulantes.
DE69103844D1 (de) Einstufiger Venenkatheter.
DE69905258T2 (de) Verwendung einer zusammensetzung mit heparin als nicht-thrombogenes oberflächenbeschichtungsmittel zur prophylaxe von arterienthrobosen
IT1316986B1 (it) Derivati glicosamminoglicani parzialmente desolfatati nonanticoagulanti ad attivita' antiangiogenica.
NO893637D0 (no) Fremgangsmaate for aa stabilisere blodkoagulasjonsfaktorer.
NZ507835A (en) Heterocyclic derivatives which inhibit factor XA
DE69832066D1 (de) Verwendung eines oligosaccharids zur vorbeugung von blutgerinnung in extrakorporale kreisläufe
ATE132757T1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
IT8722399A0 (it) Metodo per prevenire la formazionedi coaguli sanguigni nel circuito extracorporeo di apparecchi di dialisi a composizione utile per esso.
DE69130586T2 (de) Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
ATE316384T1 (de) Neue dialysemethode
DK0424351T3 (da) Anvendelse af modificeret heparin-cofaktor II
JPS5793915A (en) Thrombin inhibiting substance, manufacture and thrombin inhibiting drug composition containing same
DE69023459D1 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
ATE222103T1 (de) Inklusionskomplexe in waessriger loesung
FI915571A0 (fi) Trombinbindande substans och foerfarande foer dess framstaellning.
DE3586321D1 (de) Verwendung von 1,4-dihydropyridinderivaten.
NO995132L (no) Fremgangsmåte for reduksjon av fibrinogen
ATE98127T1 (de) Verwendung von peroxidlipiden zur herstellung eines arzneimittels zur behandlung von kreislaufinsuffizienz bei lokaler applikation.
ECSP951621A (es) Nuevas sulfonamidas case ran 4019/132
IT9040157A0 (it) Pozzetto venoso, in particolare per emodialisi
RU2001121228A (ru) Способ определения содержания трансферрина в крови
ECSP961871A (es) Nuevos derivados de piperidina (caso ran 4019/135)

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 984785

Country of ref document: EP

Representative=s name: TER MEER STEINMEISTER & PARTNER GBR PATENTANWA, DE